STIM VS MOVE Stock Comparison
Performance
STIM10/100
10/100
STIM returned -72.04% in the last 12 months. Based on SPY's performance of -13.39%, its performance is below average giving it a score of 10 of 100.
MOVE10/100
10/100
MOVE returned -60.40% in the last 12 months. Based on SPY's performance of -14.03%, its performance is below average giving it a score of 10 of 100.
Analyst Price Targets
STIM90/100
90/100
5 analysts offer 12-month price targets for STIM. Together, they have an average target of 8, the most optimistic target put STIM at 8 within 12-months and the most pessimistic has STIM at 8.
MOVE
"Analyst Price Targets" not found for MOVE
Sentiment
STIM74/100
74/100
STIM had a bullish sentiment score of 74.22% across Twitter and StockTwits over the last 12 months. It had an average of 3.11 posts, 0.22 comments, and 0.44 likes per day.
MOVE
"Sentiment" not found for MOVE
Technicals
STIM64/100
64/100
STIM receives a 64 of 100 based on 14 indicators. 8 are bullish, 4 are bearish.
MOVE10/100
10/100
MOVE receives a 10 of 100 based on 14 indicators. 0 are bullish, 12 are bearish.
Earnings
STIM24/100
24/100
STIM has missed earnings 4 times in the last 20 quarters.
MOVE
"Earnings" not found for MOVE
Profit
STIM10/100
10/100
Out of the last 20 quarters, STIM has had 0 profitable quarters and has increased their profits year over year on 0 of them.
MOVE10/100
10/100
Out of the last 16 quarters, MOVE has had 0 profitable quarters and has increased their profits year over year on 1 of them.
Volatility
STIM33/100
33/100
STIM has had a lower than average amount of volatility over the last 12 months giving it a score of 33 of 100.
MOVE34/100
34/100
MOVE has had a lower than average amount of volatility over the last 12 months giving it a score of 33 of 100.
All score calculations are broken down here to help you make more informed investing decisions
Neuronetics, Inc. Common Stock Summary
Nasdaq / STIM
Healthcare
Medical - Diagnostics & Research
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Movano Inc. Common Stock Summary
Nasdaq / MOVE
Healthcare
Medical - Devices
Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medtech and consumer devices. Its platform uses radiofrequency technology, which enables the creation of sensors that are small enough to fit into wearable devices and other small form factors. The company develops Movano Ring that measures heart rate, heart rate variability, sleep, respiration, temperature, blood oxygen saturation, steps, and calories, as well as incorporates women-centric features and design. It is also developing non-invasive continuous glucose monitoring and cuffless blood pressure monitoring features to its technology platform. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is based in Pleasanton, California.
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Compare Similar Companies
Compare STIM to other companies in the same or a similar industry.